Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Chantzoura

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The EMBO Journal|March 1, 2008
S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathwayEfthimios Prinarakis, Eleni Chantzoura, Dimitris Thanos, et al.
Biochemical and Biophysical Research Communications|November 17, 2010
Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signallingEleni Chantzoura, Efthimios Prinarakis, Dimitris Panagopoulos, et al.
Stem Cell Reports|August 18, 2015
Reprogramming Roadblocks Are System DependentEleni Chantzoura, Stavroula Skylaki, Sergio Menendez, et al.
Nature|June 4, 2013
High-resolution analysis with novel cell-surface markers identifies routes to iPS cellsJames O'Malley, Stavroula Skylaki, Kumiko A Iwabuchi, et al.
Frontiers in Immunology|July 28, 2025
CAR-iNKT cells: redefining the frontiers of cellular immunotherapyMagdalena Niedzielska, Amy Chalmers, Martyna C Popis, et al.
Cell Stem Cell|November 28, 2017
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular ReprogrammingTyson Ruetz, Ulrich Pfisterer, Bruno Di Stefano, et al.
Nature Communications|July 27, 2023
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Nature Communications|June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Cancer Immunology Research|November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunityEleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The EMBO Journal|March 1, 2008
S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathwayEfthimios Prinarakis, Eleni Chantzoura, Dimitris Thanos, et al.
Biochemical and Biophysical Research Communications|November 17, 2010
Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signallingEleni Chantzoura, Efthimios Prinarakis, Dimitris Panagopoulos, et al.
Stem Cell Reports|August 18, 2015
Reprogramming Roadblocks Are System DependentEleni Chantzoura, Stavroula Skylaki, Sergio Menendez, et al.
Nature|June 4, 2013
High-resolution analysis with novel cell-surface markers identifies routes to iPS cellsJames O'Malley, Stavroula Skylaki, Kumiko A Iwabuchi, et al.
Frontiers in Immunology|July 28, 2025
CAR-iNKT cells: redefining the frontiers of cellular immunotherapyMagdalena Niedzielska, Amy Chalmers, Martyna C Popis, et al.
Cell Stem Cell|November 28, 2017
Constitutively Active SMAD2/3 Are Broad-Scope Potentiators of Transcription-Factor-Mediated Cellular ReprogrammingTyson Ruetz, Ulrich Pfisterer, Bruno Di Stefano, et al.
Nature Communications|July 27, 2023
Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Nature Communications|June 23, 2023
Molecular mechanism of phosphopeptide neoantigen immunogenicityYury Patskovsky, Aswin Natarajan, Larysa Patskovska, et al.
Cancer Immunology Research|November 14, 2025
The allogeneic FAP-CAR-IL15 iNKT therapy MiNK-215 remodels the tumor stroma to enhance antitumor immunityEleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet, et al.
Pageof 1